Catalyst Biosciences Inc.

NASDAQ: CBIO · Real-Time Price · USD
13.89
-0.04 (-0.29%)
At close: Aug 15, 2025, 3:59 PM
14.06
1.19%
After-hours: Aug 15, 2025, 07:27 PM EDT

Catalyst Biosciences Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2022 Dec 31, 2021
Revenue
105.76M 794K 7.34M
Cost of Revenue
3.88M 798K 7.38M
Gross Profit
101.87M -4K -42K
Operating Income
16.16M -8.61M -87.89M
Interest Income
n/a 537K 39K
Pretax Income
23.22M -7.89M -87.93M
Net Income
28.54M -8.24M -87.89M
Selling & General & Admin
73.62M 17.37M 18.96M
Research & Development
12.02M 13.04M 68.89M
Other Expenses
66K n/a -78K
Operating Expenses
85.71M 30.4M 87.85M
Interest Expense
n/a 717K n/a
Selling & Marketing Expenses
57.51M n/a n/a
Cost & Expenses
89.59M 31.2M 95.23M
Income Tax Expense
-5.32M 348K -39K
Shares Outstanding (Basic)
850.95K 315.46K 306.41K
Shares Outstanding (Diluted)
1.02M 315.46K 306.41K
EPS (Basic)
34.00 -26 -287
EPS (Diluted)
28.00 -26 -287
EBITDA
16.16M -52.15M -87.6M
EBIT
n/a -7.18M -87.97M
Depreciation & Amortization
n/a -43.54M 290K